COLORADO MEDTECH INC

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Certification of termination of registration of a class of securities (Section 12(g))

Additional Information for Proxy Statement/ Votes

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

No description available

Annual report pursuant to Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d) (amendment)

No description available

5,7

Additional Information for Proxy Statement/ Votes

General form for quarterly reports under Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d) (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

No description available

General form for quarterly reports under Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

5,7

Additional Information for Proxy Statement/ Votes

5,7

Additional Information for Proxy Statement/ Votes

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

No description available

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

5,7

General form for quarterly reports under Section 13 or 15(d)

Acquisition or disposition of assets

5,7

5,7

General form for quarterly reports under Section 13 or 15(d)

Financial statements and exhibits

Annual Report Scanned (Paper)

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

7,9

4

5,7

7,9

General form for quarterly reports under Section 13 or 15(d)

7,9

5,7

General form for quarterly reports under Section 13 or 15(d)

5,7

7,9

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

5,7

7,9

Annual report pursuant to Section 13 or 15(d)

5,7

7,9

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

General form for quarterly reports under Section 13 or 15(d)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Definitive Proxy Statement

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

No description available

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

DIMUN ANTHONY J

ONODY STEPHEN K

JENSEN PETER J

KLASSON CHARLES R JR

GOULD GREGORY A

LANGENTHAL IRA M

JENKINS JOHN P

WOLFE JOHN E

WHEELER JOHN H

SULLIVAN ROBERT L

MEZEY CLIFFORD W

COLORADO MEDTECH INC

COLORADO MEDTECH INC

SOUKUP DUNCAN